Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by vicky55on Dec 03, 2020 8:29am
150 Views
Post# 32024727

RE:RE:RE:China test

RE:RE:RE:China testJe suis bien d`accord,M.Tripp et son administration nous donne du generale rien concret,la semaine prochaine des analyses vont analyser  le troisieme trimestre,je ne comprends pas,en tant investisseurs c`est un peu du n`importe quoi....si cette administration n`a pas le temps analyser ces etats resultats et ces projections et que nous avons des paroles comme tantot ou semaine prochaine ,je crois que M. Tripp devrais se poser de serieuse questions sur son entourage,ce n`est pas pour moi le chiffre d`affaire c`est utilisation qu`ils en font et je ne suis meme pas sur qu`ils connaissent leurs projections.Avance ,recul...La confiance M.Tripp se base sur des faits solide n`ont pas du liquide.Avance,Recul.En tant investisseurs nous voulons du solide.
<< Previous
Bullboard Posts
Next >>